MedTrace Logo

Copperhead Envenomation Observational Study

NCT01651299 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-05-13

No results posted yet for this study

Summary

The primary objective of the study is to evaluate the responsiveness and utility of several clinical outcome assessments in the setting of copperhead snakebite. The secondary objective is to characterize the clinical course of signs, symptoms and impairment during the recovery phase of copperhead snakebite.

Conditions

  • Copperhead Snake Envenomation

Sponsors & Collaborators

  • BTG International Inc.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-11-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01651299 on ClinicalTrials.gov